using RCM (Bernal et al., Figure 3B
In 2023, the FDA launched an investigation after GLP-1 agonist users started reporting thoughts of suicide as of January 2024, it hadnt found anything to confirm the connection, but it also said it couldnt yet rule it out, meaning its possible the drugs could cause mental health issues for some people, rather than treating or preventing them
Side effect profiles Some data suggests men may experience slightly lower rates of nausea during escalation, though this difference is modest and doesn't warrant different starting doses
When d-carnitine and l-carnitine were added in the solution of AuNRs, respectively, we observed the distinct response of AuNRs to d-carnitine and l-carnitine
An unacceptable margin for research protocols where target doses range from 100-500 micrograms